(Q48847335)

16 February 2018

title

Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant. (English)

1 reference

16 February 2018

1 reference

Helen J Lachmann

10

0 references

Dorota Rowczenio

7

object named as

Dorota Rowczenio

1 reference

16 February 2018

author name string

Prayman T Sattianayagam

1

1 reference

16 February 2018

Angelika F Hahn

2

1 reference

16 February 2018

Carol J Whelan

3

1 reference

16 February 2018

Simon D J Gibbs

4

1 reference

16 February 2018

Jennifer H Pinney

5

1 reference

16 February 2018

Arie J Stangou

6

1 reference

16 February 2018

Peter W Pflugfelder

8

1 reference

16 February 2018

Zoe Fox

9

1 reference

16 February 2018

Ashutosh D Wechalekar

11

1 reference

16 February 2018

Philip N Hawkins

12

1 reference

16 February 2018

Julian D Gillmore

13

1 reference

16 February 2018

publication date

11 October 2011

1 reference

16 February 2018

published in

European Heart Journal

1 reference

16 February 2018

volume

33

1 reference

16 February 2018

issue

9

1 reference

16 February 2018

page(s)

1120-1127

1 reference

16 February 2018

A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Transthyretin-related amyloidoses and the heart: a clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Hereditary amyloid polyneuropathy in north west Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Evaluation and management of the cardiac amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Liver Transplantation for Familial Amyloidotic Polyneuropathy (FAP): A Single-Center Experience Over 16 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

Outcome in Renal AL Amyloidosis After Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR383

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHR383

1 reference

16 February 2018

1 reference

16 February 2018